Chronic Inflammation

Condition: Chronic Inflammation  |  Category: Immune Health  |  Reviewed by: Brian Lamkin, DO

What Is Chronic Inflammation?

Chronic inflammation is a persistent, dysregulated activation of the immune system that, unlike acute inflammation, fails to resolve and instead becomes a sustained, low-grade pathological state. Acute inflammation is a precisely coordinated protective response to injury or infection that resolves when the threat is eliminated. Chronic inflammation is the failure of resolution: the inflammatory signal continues, or recurs continuously, without an active threat to defend against.

The cellular mediators of chronic inflammation include persistently activated macrophages, elevated pro-inflammatory cytokines including TNF-alpha, IL-1-beta, IL-6, and IL-17, and impaired production of pro-resolving lipid mediators including resolvins and protectins that normally terminate the acute inflammatory response. In most patients with chronic inflammation, hsCRP is mildly but persistently elevated in the 1 to 5 mg/L range, a pattern that is insufficient to trigger clinical action in standard practice but that is independently associated with cardiovascular disease, insulin resistance, neurodegeneration, and all-cause mortality in population studies.

Chronic low-grade inflammation is not a disease in itself but the common biological substrate underlying virtually every major chronic disease category. Understanding what is sustaining the inflammatory signal and directing specific interventions at those drivers is the functional medicine framework that distinguishes root-cause treatment from symptom management.

Why It Matters

Common Symptoms

Root Causes: A Functional Medicine Perspective

Chronic inflammation is maintained by one or more identifiable upstream drivers. Identifying the primary driver determines which intervention produces the most meaningful and sustained inflammatory reduction.

Gut Dysbiosis and Intestinal Permeability

LPS from gram-negative bacterial cell walls translocating through a compromised intestinal barrier is one of the most potent activators of the innate immune system available. Gut dysbiosis with overgrowth of LPS-producing species alongside intestinal permeability creates a continuous low-level LPS exposure that maintains macrophage activation and cytokine production independent of any other inflammatory driver. This is the most common single mechanism sustaining chronic inflammation in functional medicine practice.

Visceral Adiposity and Adipokine Dysregulation

Visceral fat is a continuous source of TNF-alpha, IL-6, resistin, and free fatty acids that sustain systemic inflammatory signaling. This inflammatory output is proportional to visceral fat burden and operates continuously, independently of diet on any given day. Reducing visceral fat reduces the inflammatory signal at its source rather than suppressing it downstream.

Sleep Deprivation, Chronic Stress, and Dietary Pattern

Sleep deprivation elevates NF-kB activity, the master transcriptional regulator of inflammatory gene expression, in a dose-dependent manner. Chronic psychological stress elevates cortisol and catecholamines that initially suppress inflammation but ultimately sensitize the immune system to inflammatory activation through glucocorticoid receptor downregulation. The Western dietary pattern, high in omega-6 fatty acids, refined carbohydrates, and ultra-processed foods and low in anti-inflammatory polyphenols and omega-3 fatty acids, produces a pro-inflammatory eicosanoid profile that provides the biochemical substrate for sustained inflammation.

Conventional vs Functional Medicine Approach

Key Labs to Evaluate

A complete chronic inflammation evaluation characterizes the degree and nature of inflammation and maps the most probable drivers.

How to Interpret These Labs Together

Common Patterns Seen in Patients

• The persistently elevated hsCRP patient with no identified source: hsCRP of 4.8 mg/L on three consecutive measurements over 18 months; standard workup negative for autoimmune disease, infection, or malignancy; LPS-binding protein elevated; GI-MAP shows significant gram-negative dysbiotic species and elevated calprotectin; treating the gut dysbiosis normalizes hsCRP within 3 months without any anti-inflammatory medication
• The statin-treated cardiovascular risk patient with persistent inflammation: on rosuvastatin with LDL of 85 mg/dL but hsCRP still 3.6 mg/L and omega-3 index of 3.2 percent; the lipid number is managed but the inflammatory mechanism driving the arterial risk is not; high-dose omega-3 fatty acids, gut evaluation, and Mediterranean dietary pattern reduce hsCRP to 0.8 mg/L
• The sleep-deprived professional with progressive inflammatory marker elevation: hsCRP rising from 1.2 to 3.8 mg/L over 3 years of career escalation and 5 to 6 hours of sleep per night; no dietary or physical change; NF-kB activation from sleep deprivation is the primary mechanism; sleep optimization produces more meaningful hsCRP reduction than any supplement or dietary intervention attempted
• The visceral adiposity inflammatory presentation: waist of 41 inches, hsCRP of 5.2 mg/L, TNF-alpha elevated, adiponectin of 4.8 mcg/mL; the visceral fat is the inflammatory engine and every anti-inflammatory intervention tried is working against a constant adipokine stream; visceral fat reduction through dietary and exercise intervention produces the sustained inflammatory normalization that supplementation cannot

Treatment and Optimization Strategy

Driver-Specific Intervention as the Primary Framework

Anti-inflammatory treatment that does not address the specific driver of inflammation produces temporary, incomplete, and unsustained results. The treatment hierarchy is: identify the primary driver from the lab and clinical picture, implement the intervention that directly addresses that driver, use anti-inflammatory support as adjunct during the resolution period, and monitor with serial hsCRP and driver-specific markers to confirm resolution.

What Most Doctors Miss

• An elevated hsCRP is noted but the source is never investigated: the most common clinical response to a persistently elevated hsCRP is repeat testing; the question "what is producing this inflammation?" is almost never systematically answered; without source identification, the anti-inflammatory intervention remains non-specific and produces incomplete results
• The omega-3 index is not measured: the ratio of EPA and DHA to total fatty acids in red blood cell membranes is the most reliable marker of the pro-inflammatory to pro-resolving eicosanoid balance; it is almost never measured despite being one of the most modifiable and clinically significant inflammatory drivers in the population
• Dietary refined seed oils as a primary inflammatory driver are not addressed: the shift from animal fats to refined vegetable oils high in omega-6 linoleic acid that occurred in the mid-20th century dramatically altered the eicosanoid substrate available for inflammatory prostaglandin synthesis; this dietary driver is not addressed in any standard anti-inflammatory counseling
• Sleep deprivation as a primary NF-kB activator is not prescribed against: patients told to reduce inflammation through diet and supplements while sleeping 5 to 6 hours per night are having the primary inflammatory driver ignored; sleep is the most accessible anti-inflammatory intervention available and is the one that is least prescribed

When to Seek Medical Care

Persistent hsCRP elevation above 3 mg/L on two separate measurements, joint pain with elevated inflammatory markers, or unexplained fatigue with elevated ferritin or ESR warrant systematic inflammatory driver evaluation rather than symptom management or watchful monitoring.

Seek urgent evaluation for fever with elevated inflammatory markers, rapidly worsening joint pain or swelling, symptoms suggesting acute infection or sepsis, or signs of organ involvement (chest pain, severe abdominal pain, neurological symptoms), as these require emergency evaluation to exclude acute inflammatory or infectious emergencies.

Recommended Testing

Frequently Asked Questions

How The Lamkin Clinic Approaches Chronic Inflammation

At The Lamkin Clinic, chronic inflammation evaluation always includes source investigation alongside the markers themselves. We assess hsCRP, omega-3 index, oxidized LDL, LPS-binding protein, ferritin, homocysteine, and vitamin D as a unified panel. We evaluate gut dysbiosis, intestinal permeability, visceral fat burden, sleep quality, dietary pattern, and toxic load as the specific drivers most likely to be sustaining the inflammatory signal. Treatment is directed at the driver, supported by anti-inflammatory adjuncts during resolution.

Related Conditions

Related Symptoms